Berkay Ekici

Berkay Ekici

Auto-generated profile, based on publicly available information

Berkay Ekici

Department of Cardiology, Faculty of Medicine, Ufuk University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2013 in Polish Heart Journal
Verified
Journal Article
Closed access
BEBerkay Ekici
Berkay Ekici
AEAycan Fahri Erkan
Aycan Fahri Erkan
AAAslihan Alhan
Aslihan Alhan
ISIrmak Sayin
Irmak Sayin
MAMeltem Ayli
Meltem Ayli
HTHasan Fehmi Töre
Hasan Fehmi Töre
Platelet activation and aggregation play key roles both in the pathogenesis of atherosclerosis and in the developmentof acute thrombotic events. Platelet volume is a marker of platelet activation and function, and is measured usingmean platelet volume (MPV). To determine the relationship between MPV and angiographic Gensini and SYNTAX scores, which give information about the severity and complexity of coronary artery disease (CAD). This study included 435 consecutive patients undergoing elective coronary angiography. The complete blood countand biochemical examination of blood were obtained after 12 h of fasting. The independent association between MPV andthe severity of CAD was statistically evaluated using PASW Statistics 18 for Windows. Mean age of the study population was 58.4 ± 9.3 years, of whom 196 were female (45.1%) and 239 male (54.9%). Of the patients, 63.2% had CAD, 31.7% had diabetes mellitus, 61.8% had hypertension, 56.6% had hyperlipidaemia, and 38.6% were smokers. Mean Gensini score was 20.7 ± 31.1. According to Gensini scores, 160 of the patients (36.8%) hadnormal coronary arteries (Gensini score: 0), 134 of the patients (30.8%) had minimal CAD (Gensini score: 1-19), and 141 ofthem (32.4%) had severe CAD (Gensini score ≥ 20). Mean MPV values were 8.4 ± 1.0 fL in the group that had no CAD,8.7 ± 1.0 fL in the group with minimal CAD, and 9.3 ± 1.5 fL in the group with severe CAD. According to Spearman correlationanalysis, the positive relationship found between MPV and Gensini score was statistically significant (p < 0.001,r = 0.290). Likewise, SYNTAX score was also associated with MPV (p < 0.001, r = 0.504). We determined a positive correlation between MPV and Gensini and SYNTAX scores. Therefore, this simple haematology test can be used in determining cardiovascular disease burden besides other risk factors during routine clinical practice. For further information about this topic, large-scale studies are needed.

1 January 2016 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
BEBerkay Ekici
Berkay Ekici
ATAslı Tanındı
Aslı Tanındı
GEGamze Ekici
Gamze Ekici
EDErdem Diker
Erdem Diker
This study aimed to estimate the influence of the duration of mobile phone use on heart rate variability (HRV) in healthy individuals. One hundred forty-eight individuals without any established systemic disease and who had undergone 24-h ambulatory ECG monitoring were included in the case-control study. All the individuals had been using mobile phones for more than 10 years. Three-channel 24-h Holter monitoring was performed to derive the mean heart rate, standard deviation of normal NN intervals (SDNN), standard deviation of 5-min (m) mean NN intervals (SDANN), the proportion of NN50 divided by the total number of NNs (pNN50), the root mean square differences of successive NN intervals (RMSSD), high (HF)-, low (LF)-, very low (VLF)-frequency power, total power components, and the LF/HF ratio. Individuals were divided into four groups according to their duration of mobile phone use [no mobile phone use (Control group), 60 min/day (Group 3)]. All the groups had similar features with regard to demographic and clinical characteristics. No significant arrhythmias were observed in any of the groups. The LF/HF ratio was higher, whereas the SDNN, SDANN, RMSSD, and pNN50 values were lower in the study groups than in the control group (p0.05). In this study, it was shown that the duration of mobile phone use may affect the autonomic balance in healthy subjects. The electromagnetic field created by mobile phone use may induce HRV changes in the long term.

15 July 2015 in Polish Heart Journal
Verified
Journal Article
Closed access
BEBerkay Ekici
Berkay Ekici
UKUtku Kütük
Utku Kütük
AAAslıhan Alhan
Aslıhan Alhan
HTHasan Fehmi Töre
Hasan Fehmi Töre
Many studies have shown that the serum uric acid (SUA) level is associated with atherosclerosis. To determine the relationship between the SUA level and the presence and severity of coronary heart disease (CHD). A total of 705 patients who underwent coronary angiography were included in this study. All patients were assessed for the presence of cardiovascular risk factors and ongoing medications. SUA levels were measured in all patients before the procedure after 12 h of fasting. The severity of CHD was assessed by the SYNTAX score. The independent association between the SUA and the severity of CHD was statistically evaluated using IBM SPSS Statistics 21 for Windows. The mean age of the study population was 60.2 ± 11.0 years. 252 were female (35.7%) and 453 were male (64.3%). Of the patients, 59.0% had significant CHD, 34.6% had diabetes mellitus, 67.7% had hypertension, 55.3% had hyperlipidaemia, and 45.4% were current smokers. The mean SYNTAX score was 10.6 ± 12.9. According to the SYNTAX score, 289 of the patients (41%) had normal coronary arteries and non-significant CHD (controls, SYNTAX score: 0), 236 of the patients (33.5%) had mild CHD (SYNTAX score: 1-22), 97 (13.8%) had moderate CHD (SYNTAX score: 23-32), and 83 (11.8%) had severe CHD (SYNTAX score: ≥ 33). The mean SUA values were 5.3 ± 1.5 mg/dL in the control group, 5.6 ± 1.4 mg/dL in the mild CHD group, 6.2 ± 1.6 mg/dL in the moderate CHD group, and 6.5 ± 1.7 mg/dL in the severe CHD group. According to Spearman's rho analysis, a positive correlation between the SUA levels and the SYNTAX score was determined to be statistically significant (p < 0.001, r = 0.239; p = 0.002, r = 0.148 in men; p = 0.001, r = 0.204 in women). In this study, we found a positive correlation between the SUA level and the SYNTAX score. Therefore, this routine biochemical test can be used for the evaluation of the severity of CHD besides other risk factors in clinical practice. However, larger scale randomised studies are needed to show the effects of SUA on the severity of CHD.

23 October 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
NCNeslihan Coban
Neslihan Coban
AOAybike Sena Ozuynuk
Aybike Sena Ozuynuk
AEAycan Fahri Erkan
Aycan Fahri Erkan
FGFiliz Guclu-Geyik
Filiz Guclu-Geyik
BEBerkay Ekici
Berkay Ekici

1 January 2022 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
AOAybike Sena Ozuynuk
Aybike Sena Ozuynuk
AEAycan Fahri Erkan
Aycan Fahri Erkan
NDNazli Dogan
Nazli Dogan
BEBerkay Ekici
Berkay Ekici
NENihan Erginel-Unaltuna
Nihan Erginel-Unaltuna
NCNeslihan Coban
Neslihan Coban

2 July 2021 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Open access
BEBerkay Ekici
Berkay Ekici
MYMehmet Yaman
Mehmet Yaman
MKMurathan Kucuk
Murathan Kucuk
SDSeckin Dereli
Seckin Dereli
MYMustafa Yenerçağ
Mustafa Yenerçağ
MZMehdi Zoghi
Mehdi Zoghi
Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection fraction (HFrEF). Here, we shared our experience with the use of ARNi in HFrEF from multiple centers in Turkey. The ARNi-TR is a multicenter, noninterventional, retrospective, observational study. Overall, 779 patients with HF from 22 centers in Turkey who were prescribed sacubitril/valsartan were examined. Initial clinical status, biochemical and echocardiographic parameters, and New York Heart Association functional class (NYHA-FC) values were compared with follow-up values after 1 year of ARNi use. In addition, the effect of ARNi on number of annual hospitalizations was investigated, and the patients were divided into 2 groups, depending on whether ARNi was initiated at hospitalization or under outpatient clinic control. N-terminal pro-brain natriuretic peptide (NT-proBNP), left-ventricle ejection fraction (LV-EF), and NYHA-FC values improved significantly in both groups (all parameters, p<0.001) within 1-year follow-up. In both groups, a decrease in hemoglobin A1c (HbA1c) values was observed in ARNi use (p<0.001), and a decrease in daily diuretic doses and hospitalizations owing to HF were observed after ARNi use (all comparisons, p<0.001). Hypertension (16.9%) was the most common side effect in patients using ARN. The ARNi-TR study offers comprehensive real-life data for patients using ARNi in Turkey. The use of ARNi has shown significant improvements in FC, NT-proBNP, HbA1c levels, and LV-EF. Likewise, reductions in the number of annual hospitalizations and daily furosemide doses for HF were seen in this study.